6505--Dutasteride Capsules - AvKARE LLC
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PHARMACEUTICALS (36E797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79726R0029
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents1
The Department of Veterans Affairs (VA), through its National Acquisition Center (NAC) Pharmaceuticals office, has issued an award notice for the procurement of Dutasteride Capsules, with AvKARE LLC identified as the supplier. This procurement activity falls under NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and is further classified under Product Service Code 6505, indicating a focus on pharmaceutical products.
The primary objective of this procurement is to ensure a reliable supply of Dutasteride Capsules for the VA’s healthcare system, supporting the ongoing medical needs of veterans nationwide. The scope of the contract encompasses the manufacturing and delivery of these pharmaceutical products in accordance with federal standards and VA-specific requirements. The intended outcome is to maintain consistent access to high-quality Dutasteride Capsules, thereby contributing to the effective treatment regimens prescribed within VA medical facilities.
Key requirements for this contract include adherence to stringent pharmaceutical manufacturing standards, compliance with all applicable federal regulations, and the ability to deliver the specified product in a timely and efficient manner. The expected deliverables are the provision of Dutasteride Capsules that meet the VA’s quality and safety specifications, ensuring that the end-users—veterans receiving care—benefit from reliable and effective medication.
The contracting entity for this procurement is the NAC Pharmaceuticals office, a federal office within the Department of Veterans Affairs. The primary point of contact for this award is Richard Mahario, who can be reached via email at [email protected] or by phone at 708-786-5247. The notice remains active as of the posting date, October 26, 2026, and further details, including any attachments, can be accessed through the official SAM.gov opportunity listing at https://sam.gov/opp/0806970fcf544259a8166710122c320c/view.
This procurement is classified as an award notice, indicating that the contract has already been awarded and is not currently open for new bids. There is no information provided regarding set-aside requirements or special considerations such as small business preferences or socioeconomic program participation.
Contractors evaluating similar opportunities should note that the essential elements of this contract—pharmaceutical manufacturing capabilities, compliance with federal and VA standards, and the ability to deliver consistent, high-quality products—are likely to remain constant throughout the contract lifecycle. The focus on supporting the VA’s mission to provide comprehensive healthcare to veterans underscores the importance of reliability, regulatory compliance, and product quality in all deliverables associated with this procurement.